Ligand Pharmaceuticals | LGND - Market Capitalization



Ligand Pharmaceuticals reported $2.95B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Amgen USD 150.13B 17.37B Jun/2025
Arrowhead Research USD 2.18B 433M Jun/2025
Baxter International USD 15.54B 2.02B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
Glaxosmithkline USD 82.21B 2.63B Sep/2025
Insmed USD 19.09B 5.22B Jun/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
Ligand Pharmaceuticals USD 2.19B 168M Jun/2025
MacroGenics USD 111M 34M Sep/2025
Merck USD 198.77B 27.1B Jun/2025
Pacira USD 1.11B 43M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Veracyte USD 2.12B 205M Jun/2025